Qsemble Capital Management’s Encompass Health EHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.49M Sell
14,751
-7,182
-33% -$744K 0.19% 178
2026
Q1
$2.12M Buy
21,933
+16,126
+278% +$1.65M 0.16% 189
2025
Q4
$616K Sell
5,807
-3,148
-35% -$365K 0.05% 348
2025
Q3
$1.14M Sell
8,955
-378
-4% -$45K 0.11% 227
2025
Q2
$1.14M Buy
+9,333
New +$1.07M 0.11% 235
2025
Q1
Sell
-7,066
Closed -$653K 474
2024
Q4
$653K Buy
+7,066
New +$694K 0.09% 260

Other funds holding EHC

Qsemble Capital Management's EHC Position: Q2 2026 in Review

Qsemble Capital Management reduced its Encompass Health (EHC) stake by 33% in Q2 2026, selling an estimated $744K and leaving 14,751 shares worth $1.49M. The position accounts for 0.19% of the portfolio, ranked #178.

Qsemble Capital Management first reported a position in EHC in Q4 2024 and has held it in 6 quarters since. The position peaked at $2.12M in Q1 2026. 599 funds tracked by Wall St. Rank hold EHC as of Q2 2026.

  • Qsemble Capital Management held 14,751 shares of Encompass Health worth $1.49M as of Q2 2026.
  • Qsemble Capital Management sold 7,182 Encompass Health shares in Q2 2026, an estimated $744K.
  • Encompass Health made up 0.19% of Qsemble Capital Management's portfolio in Q2 2026, its #178 holding.
  • Qsemble Capital Management first reported a position in Encompass Health in Q4 2024 and has held it in 6 quarters since.
  • Qsemble Capital Management's Encompass Health position peaked at $2.12M in Q1 2026.
  • 599 funds tracked by Wall St. Rank held Encompass Health as of Q2 2026.

Based on Qsemble Capital Management's 13F filing for Q2 2026, filed 3 Aug 2026.